Neuronetics Deferred Long Term Liab vs Short Term Debt Analysis
STIM Stock | USD 2.61 0.09 3.57% |
Neuronetics financial indicator trend analysis is infinitely more than just investigating Neuronetics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neuronetics is a good investment. Please check the relationship between Neuronetics Deferred Long Term Liab and its Short Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
Deferred Long Term Liab vs Short Term Debt
Deferred Long Term Liab vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neuronetics Deferred Long Term Liab account and Short Term Debt. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Neuronetics' Deferred Long Term Liab and Short Term Debt is -0.09. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Neuronetics, assuming nothing else is changed. The correlation between historical values of Neuronetics' Deferred Long Term Liab and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Neuronetics are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Deferred Long Term Liab i.e., Neuronetics' Deferred Long Term Liab and Short Term Debt go up and down completely randomly.
Correlation Coefficient | -0.09 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Short Term Debt
Most indicators from Neuronetics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neuronetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.As of the 17th of May 2024, Selling General Administrative is likely to drop to about 19.4 M. In addition to that, Issuance Of Capital Stock is likely to drop to 0.00
2023 | 2024 (projected) | Depreciation And Amortization | 2.0M | 1.8M | Interest Income | 4.2M | 3.3M |
Neuronetics fundamental ratios Correlations
Click cells to compare fundamentals
Neuronetics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neuronetics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 100.2M | 78.7M | 141.2M | 116.9M | 115.8M | 100.9M | |
Short Long Term Debt Total | 34.3M | 38.3M | 39.5M | 39.7M | 62.5M | 40.5M | |
Other Current Liab | 9.0M | 7.3M | 8.2M | 14.8M | 12.6M | 10.1M | |
Total Current Liabilities | 27.7M | 13.7M | 15.7M | 33.2M | 19.8M | 20.5M | |
Total Stockholder Equity | 47.9M | 25.5M | 85.2M | 57.1M | 34.2M | 35.9M | |
Other Liab | 2.1M | 1.7M | 1.5M | 829K | 746.1K | 1.2M | |
Net Tangible Assets | 46.7M | 25.5M | 85.2M | 57.1M | 65.6M | 68.9M | |
Property Plant And Equipment Net | 4.9M | 4.1M | 5.1M | 5.3M | 4.8M | 3.9M | |
Current Deferred Revenue | 2.2M | 2.0M | 2.5M | 2.0M | 1.6M | 2.2M | |
Net Debt | (41.4M) | (10.6M) | (54.6M) | (30.6M) | 2.8M | 2.9M | |
Retained Earnings | (250.1M) | (277.5M) | (308.7M) | (345.9M) | (376.1M) | (394.9M) | |
Accounts Payable | 4.6M | 3.7M | 4.3M | 2.4M | 4.8M | 3.8M | |
Cash | 75.7M | 49.0M | 94.1M | 70.3M | 59.7M | 68.7M | |
Non Current Assets Total | 11.7M | 13.6M | 25.9M | 18.1M | 22.0M | 13.4M | |
Non Currrent Assets Other | 5.1M | 7.2M | 19.1M | 11.6M | 12.8M | 7.9M | |
Other Assets | 5.6M | 12.9M | 167.1M | 9.2M | 1.0 | 0.95 | |
Long Term Debt | 19.9M | 34.6M | 35.3M | 22.8M | 59.3M | 34.0M | |
Cash And Short Term Investments | 76.6M | 50.8M | 96.3M | 71.9M | 60.6M | 69.7M | |
Net Receivables | 6.6M | 7.2M | 7.8M | 13.8M | 17.8M | 9.2M | |
Common Stock Total Equity | 177K | 186K | 191K | 273K | 314.0K | 329.6K | |
Common Stock Shares Outstanding | 18.4M | 18.8M | 25.5M | 26.9M | 28.7M | 17.5M | |
Long Term Debt Total | 30.4M | 19.9M | 34.6M | 22.8M | 26.3M | 28.2M | |
Liabilities And Stockholders Equity | 100.2M | 78.7M | 141.2M | 116.9M | 115.8M | 100.9M | |
Non Current Liabilities Total | 24.6M | 39.5M | 40.3M | 26.6M | 61.8M | 63.4M | |
Capital Surpluse | 291.9M | 297.8M | 302.8M | 402.7M | 463.1M | 238.9M | |
Inventory | 2.8M | 3.7M | 6.6M | 8.9M | 8.1M | 5.0M | |
Other Current Assets | 2.5M | 3.3M | 4.6M | 2.2M | 7.3M | 7.6M | |
Other Stockholder Equity | 297.8M | 302.8M | 393.6M | 402.7M | 410.0M | 274.4M | |
Total Liab | 52.3M | 53.2M | 56.0M | 59.8M | 81.6M | 78.2M | |
Property Plant And Equipment Gross | 4.9M | 4.1M | 5.1M | 5.3M | 7.6M | 4.3M | |
Total Current Assets | 88.5M | 65.0M | 115.3M | 98.8M | 93.8M | 87.4M | |
Common Stock | 186K | 191K | 264K | 273K | 291K | 190.6K | |
Property Plant Equipment | 4.9M | 730K | 5.1M | 2.0M | 2.3M | 2.7M | |
Net Invested Capital | 79M | 60.1M | 120.5M | 93.0M | 93.5M | 60.4M | |
Net Working Capital | 60.8M | 51.3M | 99.6M | 65.6M | 74.0M | 75.0M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Neuronetics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Neuronetics Stock analysis
When running Neuronetics' price analysis, check to measure Neuronetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuronetics is operating at the current time. Most of Neuronetics' value examination focuses on studying past and present price action to predict the probability of Neuronetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuronetics' price. Additionally, you may evaluate how the addition of Neuronetics to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Neuronetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 2.523 | Quarterly Revenue Growth 0.121 | Return On Assets (0.15) | Return On Equity (0.72) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.